Our guiding concept in designing novel drugs is to furnish the drug molecules both targeting and effector functions.
The core of our technology is built upon “multi-arm linkers”, which are synthesized using amino acids, including PEGylated amino acids, and bear multiple linking arms.
Multiple targeting or effector elements can be conjugated to the linking arms, forming bundles of cytotoxic drugs, chelators, etc., which can augment targeting or effector functions.
These bundles serve either a targeting or an effector moiety in paring respectively with an effector or targeting moiety.